How long does it take to stop taking gilitinib?

Gilitinib is an oral drug used to treat FLT3 mutation-positive acute myeloid leukemia (AML). The time to discontinuation is often affected by a variety of factors, including the patient's condition, treatment response, drug resistance, and treatment plan. Generally, the withdrawal time needs to be determined under the guidance of a doctor and adjusted according to individual circumstances.

The following are some factors that may affect the time to discontinuation of giritinib:

1.Treatment response and disease status: The time to discontinuation usually depends on the patient's response to giritinib treatment. If a patient's AML is adequately controlled and the number of leukemia cells in the bone marrow is reduced to an acceptable level, doctors may consider reducing or discontinuing giritinib.

2.Disease recurrence or progression: If a patient's disease relapses or progresses during treatment with giritinib, the doctor may recommend continuing the drug or trying other treatment options rather than discontinuing the drug.

3.Resistance: Some patients may develop resistance to giritinib, resulting in reduced therapeutic efficacy. In this case, doctors may consider changing treatment options rather than continuing giritinib.

4.Adverse reactions and tolerability: Giritinib may cause some adverse reactions, such as fatigue, nausea, vomiting, etc. Doctors may stop using giritinib temporarily or permanently if a patient develops serious adverse reactions or is unable to tolerate the drug.

5.Clinical trials and guideline recommendations: The duration of drug withdrawal may also be affected by clinical trials and treatment guidelines. Several clinical trials may evaluate the long-term treatment efficacy and safety of giritinib and provide relevant recommendations.

In general, the duration of discontinuation of giritinib should be determined by the physician based on the patient's specific condition and response to treatment. Patients should pay close attention to their doctor's advice and conduct regular follow-up visits and examinations to ensure the effectiveness and safety of treatment.